A Study to Evaluate the Safety, Tolerability and PK of SK-09
This Phase 1 trial consists of two parts: Part 1 is a Single Ascending Dose (SAD) study, and Part 2 is a Multiple Ascending Dose (MAD) study. Both parts adopt a randomized, double-blind, placebo-controlled design.
Healthy male and female participants aged 18 to 55 years (inclusive) at the time... [+3]
History or current presence of clinically significant Cardiovascular; Respirator... [+19]